Daejung Chemicals & Metals Co.Ltd (120240.KQ) stock: key figures, P/E, revenue and dividend

Materials · Commodity Chemicals · South Korea · ISIN KR7120240007

Price
14,030.00 KRW
Market cap
100.64 bn KRW
P/E (2025)
7.43
P/S (2025)
0.93
Dividend yield
3.39 %
Net margin
12.54 %
Return on equity (ROE)
7.38 %
Return on assets (ROA)
6.43 %

Daejung Chemicals & Metals Co.Ltd financials

Fiscal year20242025
Revenue92.30 bn KRW108.08 bn KRW
Gross profit19.24 bn KRW22.57 bn KRW
Operating income8.48 bn KRW11.18 bn KRW
EBIT12.13 bn KRW16.81 bn KRW
Net income9.68 bn KRW13.55 bn KRW
Diluted EPS – continuing operations1,349.63 KRW1,888.85 KRW

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Daejung Chemicals & Metals Co.Ltd

Daejung Chemicals & Metals Co., Ltd. manufactures reagents and raw materials in South Korea. The company offers reagents, including general analytical reagents, such as organic, inorganic, indicators, etc.; high-purity reagents; and specialty reagents comprising pH standard solution, normal solution, Karl Fischer moisture measurement reagents, HPLC for solvents, reagents for mineral toxic metals, etc., as well as manufactures, imports, and supplies raw material for drugs. It also provides metal oxides and metal hydroxides that include raw materials for lithium secondary battery anodes, anode materials for lithium secondary batteries, electrolyte fuel cells, solar cell materials, and capacitor materials; functional materials, which comprise cosmetic materials, materials for HPLC, and nanomaterials; and precious metal compounds. In addition, the company synthesizes general and specialty chemical products for its customers. Daejung Chemicals & Metals Co., Ltd. was founded in 1968 and is headquartered in Siheung, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.